
Clinical Research Professional with over 27 years of progressive experience across clinical operations, regulatory compliance, vendor oversight, and project management. Deep therapeutic expertise across oncology, cardiology, CNS, infectious disease, respiratory, vaccines, and rare diseases. Proven leadership in study start-up, FDA audits, ICH-GCP adherence, and cross-functional coordination with sponsors, CROs, and global regulatory agencies. Currently contributing to regulatory initiatives under FDA Code of Federal Regulations, Title 21, and completing an MPH in Epidemiology looking at a unique Artificial Intelligence Platform Deep Leukemic Cloud Platform (DLCP) which is a multi-modal diagnostic and theranostics engine built around four proprietary pillars: the LENA Code, Alercell Epigenetic Clock, LENA Score and the Alercell Digital Twin Theranostics Platform. Each pillar must stand on its own technically, yet the system will only deliver real-world value when these modules are integrated into a single, cloud-hosted workflow. (Outside advisor Mike Krieger Anthropic, Inc.) Columbia University Mailman School of Public Health.